Cara Therapeutics | CARA - Trade Debtors


Cara Therapeutics reported $2.24M in Trade Debtors for its fiscal quarter ending in March of 2025.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 148.38M 153K Mar/2026
Alterity Therapeutics Limited AUD 4.57M 1.42M Dec/2025
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Cassava Sciences USD 117K 3K Mar/2026
Chugai Pharma JPY 352.94B 90.17B Mar/2026
Cipla INR 62.19B 12.42B Mar/2026
Clal Biotechnology ILS 3.75M 186K Dec/2022
Compugen USD 2.34M 44K Mar/2026
CSL USD 4.32B 1.35B Dec/2025
Grifols EUR 1B 285.88M Dec/2025
Halozyme Therapeutics USD 457.99M 16.72M Mar/2026
J&J USD 21.33B 3.72B Dec/2025
Neurocrine Biosciences USD 768.1M 81.3M Mar/2026
Pacira USD 125.64M 1.57M Mar/2026
Pfizer USD 16.17B 332M Mar/2026
RedHill Biopharma USD 280K 5.07M Dec/2025
Supernus Pharmaceuticals USD 182.18M 5.62M Mar/2026
Vanda Pharmaceuticals USD 47.1M 4.35M Dec/2024